as of —
₹—
Change
—
Day Open
₹—
Day High
₹—
Day Low
₹—
NSE Close — 25 Sep 2026
₹115.07
Change
+1.84 (1.63%)
Open
₹113.23
Prev. Close
₹113.23
Day High
₹115.5
Day Low
₹112.2
Volume Analysis
Traded
6,263
Delivered
5,039
Delivery %
80.46%
End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.
Strengths, Weaknesses, Opportunities & Threats
Strengths (0)
No signal for this stock
Weaknesses (1)
- •Promoter holding is falling
Opportunities (0)
No signal for this stock
Threats (0)
No signal for this stock
Rule-based signals from the fundamentals below — not investment advice.
Pivot Levels
| Type | R3 | R2 | R1 | Pivot | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | ₹119.62 | ₹117.56 | ₹116.32 | ₹114.26 | ₹113.02 | ₹110.96 | ₹109.72 |
| Fibonacci | ₹117.56 | ₹116.3 | ₹115.52 | ₹114.26 | ₹113.0 | ₹112.22 | ₹110.96 |
| Camarilla | ₹115.98 | ₹115.68 | ₹115.37 | ₹114.26 | ₹114.77 | ₹114.47 | ₹114.16 |
Support/resistance levels for today, calculated from the previous trading day's high/low/close.
Absolute Returns
YTD
-4.47%
1 Week
+0.34%
1 Month
+4.12%
3 Months
-1.5%
6 Months
+12.99%
1 Year
-2.64%
2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.
Company Overview
Sector
Healthcare
Source: Screener.in (Consolidated figures) — data as of 25 Sep 2026. Not investment advice.
TopFund Analysis
Lotus Eye Hosp & Inst L lands in the middle of the pack on TopFund's composite fundamentals check within the Healthcare sector, at 50/100. The strongest factor is Corporate Governance (65/100), while Institutional Ownership (30/100) is the weakest area to weigh before deciding. Notably: Promoter holding is falling.
TopFund Score — Fundamentals Quality
50/100 — AverageData confidence: 60/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.
As of 27 Sep 2026 · How we calculate this →
Corporate Governance
Institutional Ownership
Risk & Volatility
Liquidity
Not investment advice — an automated read of public fundamentals data, for research context only.
Corporate Actions
Newspaper Advertisements published for 29th Annual General Meeting of the Company and Annual Report for the financial year 2025-26.
FY26 annual report notes turnover growth and commencement of Gobichettipalayam eye care centre.
Source: BSE regulatory filings, via Screener.in.
Shareholding Pattern
Quarter-by-quarter — Promoters, FII, DII & public holding trend
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Public | 42.43% | 43.42% | 58.6% | 59.76% | 59.97% | 59.82% | 59.73% | 59.57% | 59.33% | 59.31% | 59.85% | 59.85% |
| Promoters | 57.58% | 56.58% | 41.4% | 40.24% | 40.03% | 40.14% | 40.22% | 40.39% | 40.63% | 40.66% | 40.14% | 40.14% |
| FII | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.01% | 0.0% | 0.01% | 0.0% | 0.0% |
| DII | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.04% | 0.04% | 0.02% | 0.02% | 0.02% | 0.02% | 0.02% |
Source: Screener.in — quarterly shareholding disclosures.
Peers Comparison
Healthcare — ranked by market cap
| Company | Market Cap (Cr) | P/E | P/B | ROE |
|---|---|---|---|---|
| Lotus Eye Hosp & Inst L (this stock) | — | — | — | — |
| Sun Pharmaceutical Ind L | 444,405 | 35.2 | 5.32 | 16.0% |
| Divi S Laboratories Ltd | 255,487 | 85.8 | 15.25 | 16.5% |
| Torrent Pharmaceuticals L | 189,746 | 85.0 | 20.11 | 27.4% |
| Apollo Hospitals Enter. L | 128,055 | 60.9 | 13.51 | 21.2% |
| Zydus Lifesciences Ltd | 120,089 | 24.7 | 4.48 | 21.2% |
| Cipla Ltd | 111,060 | 31.0 | 3.23 | 11.6% |
Which Mutual Funds Hold Lotus Eye Hosp & Inst L?
Frequently Asked Questions about Lotus Eye Hosp & Inst L
Lotus Eye Hosp & Inst L (LOTUSEYE) closed at ₹115.07 on NSE on 25 September 2026, up 1.84 (1.63%) from the previous close.
Lotus Eye Hosp & Inst L trades on the NSE (National Stock Exchange of India) under the symbol LOTUSEYE.
Lotus Eye Hosp & Inst L has a TopFund Quality Score of 50/100 (Average), a composite of profitability, balance-sheet health, growth and valuation. This is an analytical score based on public data, not personalized investment advice — see the full breakdown below before deciding.
Community Sentiment
What are other investors saying about Lotus Eye Hosp & Inst L?
No votes yet — be the first to share your view.
Sign in to voteDiscussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
Sign in to join the discussionNo comments yet — start the discussion.